Here is the latest shareholding Pattern of GUFIC BIOSCIENCE. For more details, see the GUFIC BIOSCIENCE financial fact sheet and GUFIC BIOSCIENCE share price. For a sector overview, read our pharmaceuticals sector report.
No. of Mths Qtr. Ending |
3
Jun-22 |
3
Sep-22 |
3
Dec-22 |
3
Mar-23 |
3
Jun-23 |
3
Sep-23 |
3
Dec-23 |
3
Mar-24 |
||
---|---|---|---|---|---|---|---|---|---|---|
Indian Promoters | % | 75.00 | 75.00 | 75.00 | 75.00 | 75.00 | 75.00 | 72.51 | 72.51 | |
Foreign Promoters | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Total Promoters | % | 75.00 | 75.00 | 75.00 | 75.00 | 75.00 | 75.00 | 72.51 | 72.51 | |
Mutual Funds | % | 1.03 | 1.03 | 1.03 | 1.03 | 1.03 | 1.50 | 1.60 | 2.08 | |
Financial institution/Banks/Insurance | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Government | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
FII | % | 1.38 | 0.06 | 0.16 | 0.72 | 0.70 | 0.72 | 0.47 | 0.12 | |
Other | % | 0.10 | 0.13 | 0.13 | 0.13 | 0.13 | 0.14 | 0.13 | 0.12 | |
Total Institution | % | 2.51 | 1.22 | 1.32 | 1.88 | 1.86 | 2.36 | 2.20 | 2.32 | |
Bodies Corporate | % | 1.32 | 1.36 | 1.27 | 1.10 | 1.09 | 1.41 | 4.50 | 4.49 | |
Individuals | % | 17.84 | 18.28 | 18.24 | 17.83 | 17.83 | 17.16 | 16.85 | 16.72 | |
NRIs/OCBs | % | 0.51 | 0.54 | 0.57 | 0.60 | 0.68 | 0.62 | 0.60 | 0.58 | |
ADR/GDR | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Others | % | 2.82 | 3.60 | 3.61 | 3.59 | 3.54 | 3.45 | 3.34 | 3.39 | |
Total Non-Institution | % | 22.49 | 23.78 | 23.69 | 23.12 | 23.14 | 22.64 | 25.29 | 25.18 | |
Total Public | % | 25.00 | 25.00 | 25.00 | 25.00 | 25.00 | 25.00 | 27.00 | 28.00 | |
Grand Total | % | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | |
Pledged Promoter Holding | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Subscriber Feature |
More Pharmaceuticals Company Shareholding Pattern: ZYDUS LIFESCIENCES CIPLA DIVIS LABORATORIES SUN PHARMA DR. REDDYS LAB
After opening the day on high, Indian share markets continued the momentum as the session progressed and ended the higher.